Lexicon Pharmaceuticals (LXRX)

Lexicon Pharmaceuticals (LXRX) Stock Price & Analysis


LXRX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.31 - $3.79
Previous Close$3.18
Average Volume (3M)901.98K
Market Cap
Enterprise Value$545.71M
Total Cash (Recent Filing)$105.94M
Total Debt (Recent Filing)$48.84M
Price to Earnings (P/E)-5.1
Aug 02, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.63
Shares Outstanding189,561,819
10 Day Avg. Volume1,684,432
30 Day Avg. Volume901,980
Standard Deviation0.34
Financial Highlights & Ratios
Price to Book (P/B)14.87
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-4.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.37K
Enterprise Value/Gross Profit3.93K
Enterprise Value/Ebitda-10.28
Price Target Upside99.06% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Lexicon Pharmaceuticals’s price range in the past 12 months?
Lexicon Pharmaceuticals lowest stock price was $1.31 and its highest was $3.79 in the past 12 months.
    What is Lexicon Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Lexicon Pharmaceuticals’s upcoming earnings report date?
    Lexicon Pharmaceuticals’s upcoming earnings report date is Aug 02, 2023 which is in 66 days.
      How were Lexicon Pharmaceuticals’s earnings last quarter?
      Lexicon Pharmaceuticals released its earnings results on May 02, 2023. The company reported -$0.17 earnings per share for the quarter, beating the consensus estimate of -$0.179 by $0.009.
        Is Lexicon Pharmaceuticals overvalued?
        According to Wall Street analysts Lexicon Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Lexicon Pharmaceuticals pay dividends?
          Lexicon Pharmaceuticals does not currently pay dividends.
          What is Lexicon Pharmaceuticals’s EPS estimate?
          Lexicon Pharmaceuticals’s EPS estimate is -$0.18.
            How many shares outstanding does Lexicon Pharmaceuticals have?
            Lexicon Pharmaceuticals has 189,561,810 shares outstanding.
              What happened to Lexicon Pharmaceuticals’s price movement after its last earnings report?
              Lexicon Pharmaceuticals reported an EPS of -$0.17 in its last earnings report, beating expectations of -$0.179. Following the earnings report the stock price went up 15.126%.
                Which hedge fund is a major shareholder of Lexicon Pharmaceuticals?
                Among the largest hedge funds holding Lexicon Pharmaceuticals’s share is Fisher Asset Management LLC. It holds Lexicon Pharmaceuticals’s shares valued at 2M.


                  Lexicon Pharmaceuticals Stock Smart Score

                  The Lexicon Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Lexicon Pharmaceuticals

                  Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. It drug candidates include XERMELO, Sotagliflozin, LX2761, and LX9211. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.


                  Top 5 ETFs holding LXRX

                  Market Value
                  Smart Score
                  iShares NASDAQ US Biotechnology UCITS ETF
                  Schwab U.S. Broad Market ETF
                  Fidelity MSCI Health Care Index ETF
                  iShares Russell 3000 ETF
                  Invesco Nasdaq Biotechnology ETF
                  Up to five ETFs with an Outperform Smart Score that hold LXRX. The ETFs are listed according to market value of LXRX within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Biohaven Ltd.
                  Atara Biotherapeutics
                  Scholar Rock Holding
                  C4 Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis